Products

MeetBlink

AI-native

MeetBlink for every conversation

meetblink.app Productivity & Collaboration / Meetings & Note-Takers

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$20/mo
Higher than 71% of peersNiche median $14/mo
Creators
Lizdev
No social account linked
Launched
4mo ago
2026-08-05 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Live meeting assistant with knowledge, answer, advisory

    Aug 5 · 4mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-07-30

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
Unknown
10,000 credits / month
Plus
$20/mo
30,000 credits / month

Trial: Enjoy a complimentary 30-day Plus upgrade. · 1 paid tier ($20) · Observed 2026-11-06 · Pricing page

Entry price $20/mo, Higher than 71% of peers; “Meetings & Note-Takers” median is $14/mo.View pricing benchmark

Website snapshots

Indexed 2026-08-05

Key pages

Desktop & mobile archive
meetblink.app/ Snapshot 2026-11-06

Questions & evidence

How much does MeetBlink cost?
Free: Unknown; Plus: $20/mo. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does MeetBlink get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is MeetBlink and what platforms does it support?
MeetBlink is catalogued under Meetings & Note-Takers: MeetBlink for every conversation. Supported platforms: Web.

Related products in this category

Productivity & Collaboration / Meetings & Note-Takers

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.